The Catalan multiple system atrophy-registry (CMSAR)
Objective: To collect comprehensive and standardized clinical data and to create a repository of biological samples and cell lines from probable and possible MSA patients…The relationship between blood pressure, sex and survival in multiple system atrophy
Objective: To investigate the effect of BP parameters on survival in MSA patients by MSA type and sex. Background: Multiple system atrophy (MSA) is a…Non-motor symptoms in progressive supranuclear palsy
Objective: To explore the clinical correlates of Non-motor symptoms (NMS) in progressive supranuclear palsy (PSP) and their differences from healthy aging and Parkinson's disease (PD).…Movement disorders after stroke in the third Moroccan level hospital, Marrakech
Objective: The goal of this study is to describe the clinical, paraclinical and evolutive features of patients having suffered from a movement disorder in the…Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease
Objective: We aimed to directly compare middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) value of the putamen and cerebellum, and 123I-metaiodobenzylguanidine (MIBG) myocardial…Disease stage classification of the cerebellar variant of multiple system atrophy based on voxel-based morphometry
Objective: We previously reported that voxel-based morphometry (VBM) is effective for classifying the disease types causing cerebellar atrophy. In the present study, with the objective…Movement disorders in patients with Japanese encephalitis: Experience in a tertiary care hospital in north eastern region of India
Objective: Movement disorders in Japanese encephalitis is known, but under reported. In this study we tried to analyse the spectrum of movement disorders in patients…A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)
Objective: To describe the novel phenotype of a patient with an amyloid precursur protein (APP) mutation presenting with dementia and symptoms of both progressive supranulcear…Mild Parkinsonian signs and TIA/stroke
Objective: We aimed to determine if MPS increases TIA/stroke risk. Background: Mild Parkinsonian signs (MPS) are a syndrome of mild basal ganglia dysfunction characterized by…Treatment of lipopolysaccharide-induced parkinsonism
Objective: This single case report of levodopa-responsive parkinsonism, caused by an accidental systemic contamination with 10 microgram lipopolysaccharides (LPS) from Salmonella minnesota, describes the treatment…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.